KEGG   DISEASE: Tylosis with esophageal cancer
Entry
H02702                      Disease                                
Name
Tylosis with esophageal cancer
Description
Tylosis with esophageal cancer (TOC) is an autosomal-dominant syndrome characterized by palmoplantar keratoderma, oral precursor lesions, and a high lifetime risk of esophageal cancer. It has been reported that mutations in RHBDF2 cause this disease. RHBDF2 is an inactive rhomboid protease, which has recently been shown to regulate the maturation of the multi-substrate ectodomain sheddase enzyme ADAM17 in macrophages.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 14 Diseases of the skin
  Genetic or developmental disorders affecting the skin
   EC20  Genetic disorders of keratinisation
    H02702  Tylosis with esophageal cancer
Gene
RHBDF2 [HSA:79651] [KO:K27588]
Other DBs
ICD-11: EC20.31
MeSH: C536164
OMIM: 148500
Reference
  Authors
Blaydon DC, Etheridge SL, Risk JM, Hennies HC, Gay LJ, Carroll R, Plagnol V, McRonald FE, Stevens HP, Spurr NK, Bishop DT, Ellis A, Jankowski J, Field JK, Leigh IM, South AP, Kelsell DP
  Title
RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.
  Journal
Am J Hum Genet 90:340-6 (2012)
DOI:10.1016/j.ajhg.2011.12.008
Reference
  Authors
Brooke MA, Etheridge SL, Kaplan N, Simpson C, O'Toole EA, Ishida-Yamamoto A, Marches O, Getsios S, Kelsell DP
  Title
iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
  Journal
Hum Mol Genet 23:4064-76 (2014)
DOI:10.1093/hmg/ddu120
LinkDB

» Japanese version

DBGET integrated database retrieval system